Skip to main content
. 2016 Jan 4;2016(1):CD006995. doi: 10.1002/14651858.CD006995.pub2

2.3. Analysis.

Comparison 2 Any antiglucocorticoid versus placebo as adjunct to atypical antipsychotic treatment (data only for DHEA), Outcome 3 Mental state: 2b. Specific ‐ negative symptoms ‐ average endpoint scores (SANS negative subscale, high score = poor, data skewed).

Mental state: 2b. Specific ‐ negative symptoms ‐ average endpoint scores (SANS negative subscale, high score = poor, data skewed)
Study Interventions Mean SD N
Strous 2007 DHEA 34.2 20.2 20
Strous 2007 Placebo 31.2 22.7 20